Speciality: Nephrology
Description:
A warm welcome to all the medical professionals in this interesting session on Holistic CRM Care : Optimizing Kidney Protection with SLGT2-inhibitor
Holistic care in chronic kidney disease (CKD) management emphasizes kidney protection alongside overall patient well-being, with SGLT2 inhibitors playing a pivotal role. These drugs not only slow CKD progression but also address comorbidities like heart failure and diabetes, reducing hospitalization risks and enhancing quality of life. Their ability to lower albuminuria and improve glycemic control aligns with a patient-centered approach to renal care.
In optimizing kidney protection, SGLT2 inhibitors exemplify the integration of evidence-based medicine into holistic care strategies. By targeting metabolic and hemodynamic pathways, they provide multifaceted benefits, including cardiovascular risk reduction. This comprehensive approach enables healthcare providers to improve outcomes in CKD patients while addressing interconnected health challenges.
Therefore, get an overall knowledge of Holistic CRM Care : Optimizing Kidney Protection with SLGT2-inhibitor. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions
See More Webinars @ Hidoc Webinars
1.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
2.
Research uncovers hidden Australian skin cancer epidemic
3.
Immunotherapy and targeted radiation shrink liver tumors, enabling surgery
4.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
5.
The American College of Physicians updated its recommendations for colorectal cancer screening.
1.
Understanding Carcinoid Tumors: Diagnosis, Symptoms, and Treatment Options
2.
The Role of Alanine Aminotransferase in Liver Health and Disease
3.
Unveiling Canine Blood Clots Over Time: A Look at Low-Field MRI's Diagnostic Potential
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part V
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
4.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation